Finance Daily
Sunday, 22 November 2026

Bayer reaches Roundup settlement that could cost the company billions

Bayer, the agrochemical and biotechnology corporation, has reached a settlement agreement that may result in payments totaling billions of dollars to individuals who have filed lawsuits claiming that the herbicide Roundup has caused their cancer. On Friday, a Missouri judge granted final approval to a nationwide settlement that could cost Bayer as much as $7.25 billion over the upcoming years.

The settlement is designed to compensate thousands of individuals diagnosed with non-Hodgkin lymphoma, a type of blood cancer that plaintiffs assert is associated with glyphosate, the active ingredient in Roundup. Under the terms of the agreement reached in circuit court, compensation amounts for affected individuals could range from $10,000 to $165,000. This variation in compensation will depend on several factors, including the level of glyphosate exposure related to their occupation, the age at which they were diagnosed, and other relevant criteria.

Bayer's CEO, Bill Anderson, described the settlement as a "decisive milestone," emphasizing that it would help "mitigate the risks" associated with ongoing and future legal actions. Judge Timothy Boyer, who presided over the case, noted that this settlement is "among the largest in the history of mass tort personal injury class action settlements."

Earlier this year, the U.S. Supreme Court ruled in favor of Bayer, which acquired Monsanto, determining that the company could be protected from lawsuits filed in state courts regarding allegations that it failed to adequately warn consumers about the potential cancer risks associated with glyphosate. Roundup is recognized as the most widely utilized weed killer globally.

Christopher Seeger, the attorney representing the plaintiffs, stated, "Today's final approval order delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice." This latest settlement adds to a previous agreement in which Bayer consented to pay between $10 billion and $11 billion to resolve over 100,000 claims related to Roundup.

More than ten years ago, the World Health Organization's cancer research agency classified glyphosate as "probably carcinogenic to humans." This assessment has been echoed by leading scientists in environmental health, who have reiterated their concerns as recently as this year. Despite these claims, Bayer has consistently denied that its product is a cancer risk.

The Environmental Protection Agency (EPA) has also stated that it "did not identify risks of concern from glyphosate uses, including for cancer." However, the agency is currently reviewing evidence related to human health following mounting pressure from advocates and certain scientific communities.

Concerns regarding glyphosate's safety have become a significant issue for supporters of Health Secretary Robert F. Kennedy Jr. and his Make America Healthy Again initiative. Conversely, the Trump administration took steps to support Bayer, aligning with the company in the Supreme Court case and issuing an executive order aimed at promoting domestic production of glyphosate.

In recent years, Bayer has removed glyphosate from its residential products available in the United States, although the herbicide continues to be used in agricultural applications.